Chc Healthcare Group · TWSE:4164
Chc Healthcare — Investor Presentation (March 2013)
58 slides from Chc Healthcare's investor presentation, Mar 21, 2013
Slide 1: CHC Health Care Group
CHC Health Care Group 4164TT Mar. 21 ,2013
Slide 2: Disclaimer
Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Health Care Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prep
Slide 3: Company Introduction
Company Introduction Name： CHC Healthcare Group (4164 TT) Date of Establish ： 2009/11/27 (the first subsidiary-Chiu Ho Medical was founded on 1977/08/12) Chairman: Mr. Lee Pei-Lin Business Location：Taipei Major Business: Direct Selling, Leasing and Maintenance for Medical Equipment Revenue structure
Slide 4: Executive Summary
Executive Summary • We are a leading Greater China full service solution provider for high-end Radiotherapy, Neurosurgery, Ophthalmology ,Dentistry and Diagnostic Imaging equipment. • In terms of Taiwan’s installed base of radiotherapy equipment, CHC holds a dominant 55% share via its sales of Elekt
Slide 5: CHC Product portfolio
CHC Product portfolio 放射腫瘤 Radiotherapy 放射診斷 及 核子醫學 神經科學 Diagnostic Imaging Neuroscience 眼科 牙科 Ophthalmic Dental 5
Slide 6: Radiotherapy is our focus
Radiotherapy is our focus • Radiotherapy sales, revenue sharing 2012 Product Mix partnerships and services/maintenance in Taiwan accounted for 93% of 2012 revenue. • The superior returns on this business, and in particular on our revenue sharing partnerships with customers, enabled CHC to achieve an
Slide 7: Major Business
Major Business 全方位整合式服務 Full service solution Provider Direct Selling 醫療設備直 接銷售 Maintenance 保養維修技 Revenue 術收入 Sharing 租賃合作模式 7
Slide 8: A Robust and Flexible Distribution Channel Drives CHC Value Creation
A Robust and Flexible Distribution Channel Drives CHC Value Creation We have designed and built cancer treatment centers across Taiwan, establishing revenue-sharing agreements with many large-scale hospitals: • CHC's three major product lines (Elekta, TomoTherapy, Gamma Knife) are used in 52 of the
Slide 9: Some of our Key Cancer Treatment Revenue Sharing Partners
Some of our Key Cancer Treatment Revenue Sharing Partners • Taipei Veterans General Hospital • Taipei Medical University Hospital • National Taiwan University Hospital • Taipei City Hospital Zhongxing Branch • MacKay Memorial Hospital • Taipei City Hospital – Renai Branch • Shuang Ho Hospital • Wan
Slide 10: CHC Provides a Full Spectrum of Services
CHC Provides a Full Spectrum of Services Manufacturer Clinic Planning Product Specialty Site Categories: Construction Radiotherapy CHC Health Care Group Operational Neurology Consulting Ophthalmology Revenue Distribution Services Installation Dentistry Sharing Partnerships Diagnostic Education Imagi
Slide 11: We Know the Products, Markets and Regulations
We Know the Products, Markets and Regulations CHC BOD Members Lee, Pei-Lin MBA Ho, Chang-Jian MD Independent Director Chairman VS, National Taiwan Univ. Hospital Lee, Tien-Ying MD Chen, Gui-Duan PhD Director Independent Director Mackay Memorial Hospital ED, Taiwan CPA Association Chang, Hang MD PhD
Slide 12: We Know the Products, Markets and Regulations
We Know the Products, Markets and Regulations Management Team Chen Kung-Yu Huang, Shi-Fen MBA CEO ; GM, Beijing Chiu Ho GM, Guangzhou Chiu Ho Sales Director, GE Healthcare Sales Director, COWealth Group Lee, Tien-Ying MD Chen, Yi-Chun VP VP, Financial Accounting Dept. Mackay Memorial Hospital AVP, P
Slide 13: We work with world-renowned brands
We work with world-renowned brands Radiotherapy and Neurology Ophthalmology and Dentistry 13
Slide 14: We Have an Experienced Medical Consulting Team
We Have an Experienced Medical Consulting Team • CHC’s experienced consulting and service team is the critical success factor in offering medical equipment turnkey solutions to hospitals and clinics. The manufacturers in the US, Europe and Japan rely on CHC to provide this operational support and af
Slide 15: Dedicated and Certified Consulting Team
Dedicated and Certified Consulting Team installation, maintenance and upgrade services With its dedicated team of +60 fully –trained and long-tenured engineers CHC also provides turnkey solutions including installation, clinic planning, maintenance services and the upgrade of system….etc. CHC
Slide 16: Business Plan in Great China
Business Plan in Great China SWISSRAY ELEKTA Dental 16
Slide 17: Guangzhou Chiu Ho Medical System Co.
广州市久和医疗器械有限公司 Guangzhou Chiu Ho Medical System Co. Mainland China: 2011 through the CHC Healthcare (BVI) Limited investment in Guangzhou Chiu Ho Medical System company , distribution of ELEKTA radiation oncology equipment in south of China, the expansion path scale of cancer treatment equipment. 17
Slide 18: RUSSIA > \
RUSSIA > \ ; KAZAKHSTAN MONGOLIA SOUTH ‘KOREA : o #9 East Chins Sea INDIA BANGLADESH a TAIWAN J | id ong Kong 'Y BURM/ fa &\ LA South China {THAILAND} a Sea 0 608 km 18 ~ ( Se
Slide 19: Distribution Provinces
Distribution Provinces • 福建 Fujian • 广东 Guangdong • 广西 Guangxi • 湖南 Hunan • 海南 Hainan Guangzhou Chiu Ho Medical System Co. 19
Slide 20: A complete portfolio for Radiation Therapy
A complete portfolio for Radiation Therapy Compact™ Precise Treatment System™ Precise Table MOSAIQ® Monaco® Elekta Synergy® Multileaf Collimator X-Ray Volume Imaging iViewGT™ VMAT Active Breathing HexaPOD evo RT System Coordinator™ with BodyFix™ 20
Slide 21: CHC's Competitive Advantage in China
CHC’s Competitive Advantage in China • Complete Product Line • Successful Taiwan Experience • Full Service Solution Capability • Clinical Education • Flexible Sales Model • Cross-strait Medical Conferences 21
Slide 22: We are Transplanting our Model into China
We are Transplanting our Model into China • Starting in 2012, CHC established a regional distribution platform. We plan to leverage our full service solution capabilities – which have been developed over the course 30 years of experience in Taiwan – to expand our business into the China market. • We
Slide 23: CHC's China Strategy
CHC’s China Strategy • Our China team is led by veteran health care professionals with experience in the China market. • We will start building our franchise in areas of China that are demographically similar to Taiwan. • We are targeting hospitals and clinics which are managed and/or owned by Taiwa
Slide 24: Increased cancer incidence
Increased cancer incidence Improved diagnosis, demographics, higher life expectancy Number of new cancer cases Millions 25 20 Total 15 Men 10 Women 5 0 2002 2010 2020 2030 WHO forecast of new cancer excluding melanoma 24
Slide 25: The Role of Radiotherapy in Cancer Treatment
The Role of Radiotherapy in Cancer Treatment • The most common cancer treatments include surgery, chemotherapy, radiotherapy, immunotherapy and monoclonal antibody therapy. What is radiotherapy? • It is the medical use of ionizing radiation to control or kill malignant cancer cells. • External beam
Slide 26: Radiotherapy Equipment Market in China
Radiotherapy Equipment Market in China • There are about 1,300 ClassⅢ Hospitals hospitals in China；7 of Top 10 clinics ClassⅢ (~1,300) >500 beds have Elekta equipment classⅡ hospitals • Third largest medical device market in (~6,000) > 100 beds the world- domestic manufacturers in low technology sec
Slide 27: Greater China Demand for Radiotherapy Services is Strong and Growing
Greater China Demand for Radiotherapy Services is Strong and Growing • In 2011, cancer accounted for 28% and 26% of deaths, respectively, in Taiwan and China, and was the #1 cause of death in both regions. • From 2006-10, there were around 120,000 new cancer cases recorded in Taiwan annually. Radiot
Slide 28: Greater China Ophthalmology and Dentistry Market: Steady Growth
Greater China Ophthalmology and Dentistry Market: Steady Growth • Based on Taiwan Bureau of Health • There are 6,000 dental clinics in Promotion data, cataracts are the Taiwan. This number increases by an 2nd most common chronic disease avg of 80 clinics/year. Each clinic for the elderly. Yet the oc
Slide 29: Our vision
Our vision IBA Proton Therapy Equipment Philips Nuclear Medicine and PET, MRI, CT and Interventional Product Diagnostic Imaging Equipment Medical Imaging Equipment Pipeline Swissray Radiological Imaging Equipment Product Line (Exclusive Greater China Distributor) Expansion Ophthalmology & Dentistry
Slide 30: We are Aggressively Introducing New Products
We are Aggressively Introducing New Products Diagnostic X-Ray (DR X-Ray) Computed Interventional X-Ray Tomography (CT) Proton therapy Positron Emission Tomography/ Single Magnetic Photon Emission Resonance Computed Tomography Imaging (MRI) (PET/CT & SPECT) 30
Slide 31: ddR Systems
ddR Systems 直接數位式X光診斷影像系統 Chiu Ho Med is the SWISSRAY’s Exclusive Distributor in Great China 31 31
Slide 32: Solutions for any DR Application
Solutions for any DR Application 32
Slide 33: RUSSIA ‘
RUSSIA 5 ‘ KAZAKHSTAN MONGOLIA a = > = ud sein =~ —_ INNER MONGOLIA pei Blea GANSU _ .= © Er ea i] ae “(Sanu BEBE! TH NINGXIA Yetloy, SHANDONG 2 %, CHINA - ig SICHUAN ANHU! Sas SHANGHAI CHO! fas B zZ East > JANGXI og Chins HUNAN 3 Sea NDI C = GUIZHOU t F INDIA : } BANGLADESH et S vid GUANGXI TAIWAN
Slide 34: Digital Radiography (DR) Market
Digital Radiography (DR) Market Global X-Ray Systems Market, Revenue Forecast China X-Ray Systems Market, Revenue Forecast US$ mn US$ mn 5000 800 Digital Analog 4500 398 390 700 Digital Analog 189 384 4000 378 178 374 600 371 169 3500 370 370 160 500 3000 151 143 2500 400 135 128 4387 2000 3995 4184
Slide 35: China Will be Driving the Growth of the Diagnostics Market
China Will be Driving the Growth of the Diagnostics Market Source: Frost & Sullivan 35
Slide 36: Diagnostic Imaging Products Account for Over 25% of the Global Medical Device Market
Diagnostic Imaging Products Account for Over 25% of the Global Medical Device Market Global Medical Device market breakdown Global Diagnostic Imaging Market breakdown Medical supply, 14.60% Bone densitometer, Others, 30.30% 2.00% Other, 0.70% CT, 9.80% X ray, 31.70% Diagnotic Imaging, 25.80% PET, 17
Slide 37: Proton Therapy
質子治療系統 Proton Therapy 37
Slide 38: Photons and Charged Particles
Photons and Charged Particles Electrons (21 MeV)| Carbon (270 MeV/u) hv A Photons | b (ae s & ba 2 6 Ac] o Aa ia B Qo m% & nm Ss — 4+ Protons give Conformal Dose and Low Integral Dose GPAC Confidential 2008
Slide 39: A al
~~ - A al o al — oO (e) a oe) fe) — ° 6 P= [-*) "a ‘So Cy « 39 39
Slide 40: 40
40 40
Slide 41: Conventional Proton Gantry
Conventional Proton Gantry 機身 41
Slide 42: IBA is the worldwide leader in Proton Therapy
IBA is the worldwide leader in Proton Therapy.
Slide 43: IBA Particle Therapy
IBA Particle Therapy Truly Accessible Making Proton Clinical Experience Therapy a reality for 25 centers worldwide Planning Experience TAIWAN can access PT Training Experience successfully with IBA 43
Slide 44: Truly Accessible – Clinical Experience
Truly Accessible – Clinical Experience Clinical Operations (12) Installation (13) Total Capacity: 27,000 patients per year 44
Slide 45: Proton Pencil Beam Scanning
Proton Pencil Beam Scanning 45 45
Slide 46: ProteusPLUS and ProteusONE
IBA 質子治療系統 Proton Therapy ProteusPLUSTM UNIVERSAL PROTON THERAPY SOLUTION Active and Passive treatment modes ProteusONETM COMPACT PROTON THERAPY SOLUTION Active treatment only 46
Slide 47: A al
~~ - A al o al — oO (e) a oe) fe) — ° 6 P= [-*) "a ‘So Cy « 47 47
Slide 48: 48
48 48
Slide 49: Conventional Proton Gantry
Conventional Proton Gantry 機身 49
Slide 50: Figure 1. Proton Beam Therapy Blueprint
50 Figure 1. Proton Beam Therapy Blueprint The proton therapy suite includes a 440,000- pound cydotron to accelerate the protons to one of the three gantry-fitted treatment rooms or the fixed-beam room; a milling shop for the fabrica- tion of patient-specific devices, an anesthesia and infusion suit
Slide 51: Figure 1. Proton Beam Therapy Blueprint
51 Figure 1. Proton Beam Therapy Blueprint The proton therapy suite includes a 440,000- pound cyclotron to accelerate the protons to one of the three gantry-fitted treatment rooms or the fixed-beam room; a milling shop for the fabrica- tion of patient-specific devices, an anesthesia and infusion sui
Slide 52: Compact Cyclotron + Compact Gantry
52 Compact Cyclotron + Compact Gantry Pans et rae] [PDO reo pS /
Slide 53: Proton Room Flexibility
Proton Room Flexibility Fixed Beam Treatment Room 360o Gantry Treatment Room Compact Gantry Treatment Room Small Fixed Beam Treatment Room 53
Slide 54: Profitable PT center for 1/6 the size
Proton Design Flexibility ProteusPLUS ProteusONE 1800 m² 300 m² Profitable PT center for 1/6 the size 54
Slide 55: m m
32 m 55 42 m
Slide 56: Proton Therapy Center
Proton Therapy Center 56
Slide 57: Our mission: To be a leader of health care provider in Asia-Pacific
Our mission: To be a leader of health care provider in Asia-Pacific US美國 SE瑞典 DE德國 CH瑞士 JP旦本 NL 荷蘭 CH瑞士 US美國 DE德國 NL荷蘭 US美國 DE德國 IL以色列 US美國 DE德國 57 57
Slide 58: Thank you
Human Care Makes the Future Possible Thank you se 58
CHC Healthcare Group — Investor Presentation (March 2013) on 6ix